This inventor holds 1 USPTO granted patent. Top assignee: Zealand Pharma A/s. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Innovations of Kenneth W Harlow
Introduction
Kenneth W Harlow is a notable inventor based in Frederiksberg, Denmark. He has made significant contributions to the field of biochemistry, particularly in the development of peptide conjugates. His work has implications for medical treatments, especially concerning disorders influenced by nociceptin and related opioid-like peptides.
Latest Patents
Kenneth W Harlow holds a patent for "Diuretic peptide conjugates." This patent discloses a variety of peptide conjugates represented by the general formula: R-Z-X-Z'-R. The patent includes methods for making and using these conjugates. Additionally, it provides antibodies that specifically bind to the peptide conjugates. The present invention has a wide spectrum of important applications, including use in the treatment of disorders impacted by nociceptin and related opioid-like peptides. He has 1 patent to his name.
Career Highlights
Harlow is associated with Zealand Pharma A/S, a company that focuses on the development of innovative peptide-based therapeutics. His work at Zealand Pharma has allowed him to contribute to advancements in medical science, particularly in the area of drug development.
Collaborations
Kenneth W Harlow has collaborated with notable colleagues such as Bjarne Due Larsen and Jørgen Søberg Petersen. Their combined expertise has likely enhanced the research and development efforts at Zealand Pharma.
Conclusion
Kenneth W Harlow's innovative work in peptide conjugates showcases his commitment to advancing medical science. His contributions have the potential to impact the treatment of various disorders significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
